AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification
Clinical trial NCT03253679 · COMPLETED
Trial details
- NCT number
- NCT03253679
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2022-10-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.